Cited by 78Smoking Behavior and CessationSchizophrenia research and treatmentNicotinic Acetylcholine Receptors Study

Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study

Open access
Allen, Michael H., Debanné, Martin, Lazignac, Coralie, Adam, Eric, Dickinson, L. Miriam, Damsa, Cristian·2011·American Journal of Psychiatry

Abstract

OBJECTIVE: The authors conducted a randomized, placebo-controlled study of nicotine replacement therapy for the reduction of agitation and aggression in smokers with schizophrenia. METHOD: Participants were 40 smokers 18-65 years of age admitted to a psychiatric emergency service with a diagnosis of schizophrenia confirmed by the Mini International Neuropsychiatric Interview. Patients were screened for agitation with the excited component subscale of the Positive and Negative Syndrome Scale (PANSS) and for nicotine dependence with the Fagerström Test for Nicotine Dependence. A score of at least 14 on the PANSS excited component subscale and at least 6 on the Fagerström test were required for study eligibility. Participants in the nicotine replacement group received a 21-mg nicotine transdermal patch, and those in the placebo group were treated with a placebo patch. Participants received usual care with antipsychotics. The Agitated Behavior Scale and other agitation measures were administered at baseline and again at 4 and 24 hours. RESULTS: At baseline, participants were at least moderately agitated, and 28% reported aggressive behavior in the previous week. The mean Agitated Behavior Scale score for the nicotine replacement group was 33% lower at 4 hours and 23% lower at 24 hours than for the placebo group. Participants with lower levels of nicotine dependence responded better than those with higher levels of dependence. CONCLUSIONS: The drug-placebo difference in this study was similar to that obtained in trials of parenteral antipsychotics in similar populations. This finding suggests that in patients with schizophrenia, smoking status should be included in the assessment of agitation and nicotine replacement included in the treatment of those who are smokers.

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2010.10040569

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Allen, M. H., Debanné, M., Lazignac, C., Adam, E., Dickinson, L. M., & Damsa, C.
Affiliations
  • University of Geneva (CH)
  • From the Depression Center, University of Colorado School of Medicine, Aurora; Faculty of Psychology and Faculty of Medicine, University of Geneva, Switzerland; and International Mental Health SA, Grand Lancy, Switzerland.
Venue
American Journal of Psychiatry
Published
2011-04
Volume
168
Issue
4
Pages
395-399
ISSN
  • 0002-953X (ISSN-L)
  • 1535-7228
OpenAlex
W2155255064
Cited by
78
References
22
Citations by year
2026: 3 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 8 · 2016: 9 · 2015: 6 · 2014: 5 · 2013: 5 · 2012: 5
FWCI
4.15
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • American Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords
nicotine replacement therapy, schizophrenia, agitation, aggression, smoking, nicotine dependence, psychiatric emergency care, antipsychotic drugs
MeSH terms
Adolescent, Adult, Aged, Double-Blind Method, Emergency Service, Hospital, Female, Humans, Male, Middle Aged, Nicotine, Psychiatric Department, Hospital, Psychiatric Status Rating Scales, Psychomotor Agitation, Schizophrenia, Schizophrenic Psychology, Smoking, Violence, Smoking Cessation, Young Adult, Transdermal Patch

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review